Live from the NIH registry
Studies recruiting near Lafayette right now
Top 25 of 54 recruiting studies, sorted by proximity — each links to its official registry page
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Velocity Clinical Research, Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Sparrow Pharmaceuticals
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Southern Urology — Lafayette, Louisiana (1.3 mi)
· Sponsor: Pacific Edge Limited
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: DalCor Pharmaceuticals
Tissue Repair Gel in Venous Leg Ulcers (US)
Venous Leg Ulcer, Venous Ulcer
Phase 3
Interventional 312 participants sought
Clincial Research Site 01 — Lafayette, Louisiana (1.3 mi)
· Sponsor: TR Therapeutics
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
APOL1-Mediated Kidney Disease
Phase 2
Interventional 136 participants sought
Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: AstraZeneca
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Cancer Center of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: National Cancer Institute (NCI)
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Phase 3
Interventional 5,700 participants sought
Horizon Research Grp — Lafayette, Louisiana (1.3 mi)
· Sponsor: Novartis Pharmaceuticals
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Crohn's Disease, Obesity or Overweight
Phase 3
Interventional 290 participants sought
Care Access - New Iberia — New Iberia, Louisiana (19.1 mi)
· Sponsor: Eli Lilly and Company
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
Non-Muscle Invasive Bladder Neoplasms
Phase 1, Phase 2
Interventional 235 participants sought
Southern Urology LLC — Lafayette, Louisiana (1.3 mi)
· Sponsor: Janssen Research & Development, LLC
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Peripheral Vascular Diseases
N/A
Observational 5,000 participants sought
Cardiovascular Institute of the South — Lafayette, Louisiana (1.3 mi)
· Sponsor: Boston Scientific Corporation
A Study of BLB-201 RSV Vaccine in Infants and Children
Respiratory Syncytial Virus Infections
Phase 1, Phase 2
Interventional 137 participants sought
Velocity Clinical Research - Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Blue Lake Biotechnology Inc.
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Cancer Center of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
The THOR IDE Study
Peripheral Artery Disease, Peripheral Artery Stenosis
N/A
Interventional 155 participants sought
Cardiovascular Institute of the South — Lafayette, Louisiana (1.3 mi)
· Sponsor: Philips Clinical & Medical Affairs Global
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: 89bio, Inc.
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,250 participants sought
Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: AstraZeneca
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Clostridioides Difficile Associated Disease
Phase 3
Interventional 32,000 participants sought
Ochsner Lafayette General Medical Center — Lafayette, Louisiana (1.3 mi)
· Sponsor: Pfizer
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
Influenza
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Hoffmann-La Roche
MagDI U.S. Registry
Anastomosis, Surgical, Internal Hernia
N/A
Observational 106 participants sought
Ochsner Clinic Foundation — Lafayette, Louisiana (1.3 mi)
· Sponsor: GT Metabolic Solutions, Inc.
Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)
Focal Seizure
Phase 2, Phase 3
Interventional 230 participants sought
Praxis Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: Praxis Precision Medicines
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC)
Phase 2
Interventional 140 participants sought
Mirador Therapeutics Selected Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: Mirador Therapeutics, Inc.
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 734 participants sought
Velocity Clinical Research - Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Peripheral Arterial Disease
N/A
Interventional 159 participants sought
Cardiovascular Institute of the South - Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Avantec Vascular
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
Idiopathic Short Stature
Phase 2
Interventional 100 participants sought
Velocity Clinical Research - MedPharmics - Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: BioMarin Pharmaceutical
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer
Phase 2
Interventional 131 participants sought
Southern Urology — Lafayette, Louisiana (1.3 mi)
· Sponsor: Protara Therapeutics